Evidence map›Paper›PMID 22930807›Full record

ArticleThe Journal of infectious diseases2012

Permeases of the sap transporter are required for cathelicidin resistance and virulence of Haemophilus ducreyi in humans.

Sherri D Rinker, Xiaoping Gu, Kate R Fortney, Beth W Zwickl, Barry P Katz, Diane M Janowicz, Stanley M Spinola, Margaret E Bauer

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  2. Review
  3. Article
  4. AInfection and immunity · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Interactions of the Skin PathogenFrontiers in immunology · 2020
    Review
  11. Review
  12. Role ofInfection and immunity · 2017
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sherri D RinkerDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.
Xiaoping Gu
Kate R Fortney
Beth W Zwickl
Barry P Katz
Diane M Janowicz
Stanley M Spinola
Margaret E Bauer
Indiana University – Purdue University Indianapolis · US

Funding

VIRAL DETERMINANTS OF HSV DISEASE IN MICEU19AI031494 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SPINOLA, STANLEY M. · 1995 to 2009
$13.6M
Immunology and Infectious Diseases Training ProgramT32AI060519 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARK H KAPLAN · 2004 to 2026
$6.0M
Training in STIs and infections of global health significanceT32AI007637 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI WOOLS-KALOUSTIAN, KARA KAY · 2001 to 2020
$3.4M
Mechanisms of Sap-mediated Antimicrobial Peptide ResistanceR21AI096056 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI BAUER, MARGARET E · 2011 to 2012
$424k
Haemophilus ducreyi Resistance to Antimicrobial PeptidesR21AI075008 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI BAUER, MARGARET E · 2007 to 2008
$412k
NCRR NIH HHS UL RR052761NIAID NIH HHS R21 AI075008NIAID NIH HHS R21 AI096056NIAID NIH HHS T32 AI007637NIAID NIH HHS T32 AI060519NIAID NIH HHS U19 AI031494NIAID NIH HHS U19 AI31494
6 · The paper itself

Abstract

backgroundHaemophilus ducreyi encounters several classes of antimicrobial peptides (APs) in vivo and utilizes the sensitive-to-antimicrobial-peptides (Sap) transporter as one mechanism of AP resistance. A mutant lacking the periplasmic solute-binding component, SapA, was somewhat more sensitive to the cathelicidin LL-37 than the parent strain and was partially attenuated for virulence. The partial attenuation led us to question whether the transporter is fully abrogated in the sapA mutant.

methodsWe generated a nonpolar sapBC mutant, which lacks both inner membrane permeases of the Sap transporter, and tested the mutant for virulence in human volunteers. In vitro, we compared LL-37 resistance phenotypes of the sapBC and sapA mutants.

resultsUnlike the sapA mutant, the sapBC mutant was fully attenuated for virulence in human volunteers. In vitro, the sapBC mutant exhibited significantly greater sensitivity than the sapA mutant to killing by LL-37. Similar to the sapA mutant, the sapBC mutant did not affect H. ducreyi's resistance to human defensins.

conclusionsCompared with the sapA mutant, the sapBC mutant exhibited greater attenuation in vivo, which directly correlated with increased sensitivity to LL-37 in vitro. These results strongly suggest that the SapBC channel retains activity when SapA is removed.

Indexed as

Drug Resistance, BacterialAdultAntimicrobial Cationic PeptidesCathelicidinsChancroidFemaleGene DeletionHaemophilus ducreyiHuman ExperimentationHumansMaleMembrane Transport ProteinsMicrobial Sensitivity TestsMiddle AgedVirulenceVirulence FactorsAntimicrobial Cationic PeptidesCathelicidinsMembrane Transport ProteinsVirulence Factors

Identifiers

PMID22930807
PMCPMC3529601
OpenAlexW2115291381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.